Recurrent High-Grade Glioma
Temsirolimus in Recurrent High-Grade Glioma
A Phase 0 dose-escalation study using superselective intra-arterial cerebral infusion of temsirolimus for the treatment of recurrent high-grade glioma.
Learn More
AZD1390 FOR RECURRENT GLIOBLASTOMA
A Phase 0/1b clinical trial to evaluate AZD1390 in patients with recurrent glioblastoma.
Learn More
SONODYNAMIC THERAPY IN RECURRENT HIGH-GRADE GLIOMA
A Phase 0 research study of intravenous Aminolevulinic Acid Hydrochloride (ALA) and MR-guided focused ultrasound device (MRgFUS) in recurrent high-grade glioma patients.
Learn More
RIBOCICLIB PLUS EVEROLIMUS FOR RECURRENT HIGH-GRADE GLIOMA
A Phase 0/2 study of ribociclib in combination with everolimus in preoperative Rb-intact recurrent high-grade glioma patients scheduled for resection.
Learn More